 |
市场调查报告书
商品编码
1629684
眩晕治疗市场按类型、治疗方法、给药途径、最终用户和地区划分Vertigo Treatments Market, By Type, By Treatment, By Route of Administration, By End User, By Geography |
||||||
2024 年全球眩晕治疗市场规模估计为 15.3 亿美元，预计 2031 年将达到 22.4 亿美元，2024 年至 2031 年的复合年增长率为 5.6%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2023 | 2024 年的市场规模 | 15.3亿美元 |
| 效能资料 | 2019 年至 2023 年 | 预测期 | 2024 年至 2031 年 |
| 预测期间 2024 年至 2031 年复合年增长率： | 5.60% | 2031 年价值预测 | 22.4亿美元 |
头晕是一种感觉自己或周围环境在移动或旋转的状态，即使这种感觉是静止的。这通常是由于内耳不平衡引起的。人口老化是导致主要市场头晕盛行率上升的重要因素。根据美国国家医学图书馆 2023 年 6 月的估计，超过 12% 的 60 岁以上的成年人在一生中的某个时刻会出现头晕症状。治疗头晕的治疗方法有很多种，包括药物治疗、前庭復健治疗、平衡再教育计画和手术治疗。诊断技术的进步和新型治疗剂的引入正在支持市场扩张。
市场动态：
老年人口的增加、引起头晕的神经系统疾病病例的增加以及新产品的核准和推出是推动全球头晕治疗市场发展的一些主要因素。然而，与手术治疗相关的风险、与眩晕相关的社会耻辱以及品牌药物的高成本是限制市场成长的一些挑战。从机会角度来看，未经治疗的头晕给全世界带来了沉重的经济负担。开发中国家医疗旅游业的发展和头晕管理设备的技术发展为市场参与者提供了宝贵的视角。医疗设备创新者和医疗保健提供者之间的合作可以帮助更有效地解决未满足的需求。
本研究的主要特点
本报告对全球眩晕治疗市场进行了详细分析，并以 2023 年为基准年，给出了预测期（2024-2031 年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
它根据公司亮点、产品系列、关键亮点、业绩和策略等参数列出了全球眩晕治疗市场的主要企业简介。
主要公司包括美敦力雅培实验室、西门子医疗、强生、奥迪康、科利耳有限公司、Auris Medical Holding AG、Otonomy, Inc.、Sensorion SA、Sound Pharmaceuticals Inc.、葛兰素史克 (GSK)、默克公司、辉瑞耳公司、诺华公司和拜耳公司。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球眩晕治疗市场报告涉及该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过用于分析全球眩晕治疗市场的各种策略矩阵更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- PORTER 分析
- 併购情景
- 产业趋势
4. 2019 年至 2031 年全球眩晕治疗市场（按类型）
- 中枢性眩晕
- 周围性眩晕
5. 全球眩晕治疗市场，依治疗方法，2019-2031 年
- 药品
- 抗胆碱能药物
- 抗组织胺药
- 苯二氮平类
- 其他的
- 手术/治疗
6. 2019 年至 2031 年按给药途径分類的全球眩晕治疗市场
- 口服
- 外用
- 肠外
- 其他的
7. 全球眩晕治疗市场，依最终使用者划分，2019 年至 2031 年
- 医院
- 诊所
- 其他的
8. 2019 年至 2031 年全球眩晕治疗市场（按地区划分）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第九章 竞争格局
- Medtronic
- Abbott Laboratories
- Siemens Healthineers
- Johnson & Johnson
- Oticon
- Cochlear Limited
- Auris Medical Holding AG
- Otonomy, Inc.
- Sensorion SA
- Sound Pharmaceuticals, Inc.
- GSK（GlaxoSmithKline）
- Merck & Co.
- Pfizer Inc.
- Novartis AG
- Bayer AG
第 10 章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第 11 章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The global vertigo treatments market is estimated to be valued at USD 1.53 Bn in 2024 and is expected to reach USD 2.24 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.53 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 5.60% | 2031 Value Projection: | US$ 2.24 Bn |
Vertigo refers to a condition where a person feels as if they or everything around them is moving or spinning, even though they are stationary. It is typically caused due to imbalance in the inner ear. Aging population has contributed greatly to the rising prevalence of vertigo across major markets. According to the National Library of Medicine estimates in June 2023, over 12% of adults aged 60 years and above experience vertigo at least once in their lifetime. Various treatment options are available for vertigo including medications, vestibular rehabilitation therapy, balance retraining programs, surgical treatments, etc. Advancements in diagnosis and introduction of novel therapeutics are supporting the market expansion.
Market Dynamics:
Rising geriatric populace, growing cases of neurological disorders causing vertigo, and new product approvals and launches are some of the key factors driving the global vertigo treatments market. However, risks associated with surgical treatments, social stigma around vertigo and high costs of branded therapies are certain challenges restraining the market growth. On the opportunities side, untreated vertigo imposes a huge economic burden globally. Growing medical tourism in developing nations and technological developments in vertigo management devices present valuable prospects for market players. Collaborations between medical device innovators and healthcare providers can help address unmet needs more effectively.
Key Features of the Study:
This report provides in-depth analysis of the global vertigo treatments market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vertigo treatments market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic Abbott Laboratories, Siemens Healthineers, Johnson & Johnson, Oticon, Cochlear Limited, Auris Medical Holding AG, Otonomy, Inc., Sensorion SA, Sound Pharmaceuticals Inc., GSK (GlaxoSmithKline), Merck & Co., Pfizer Inc., Novartis AG, and Bayer AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vertigo treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vertigo treatments market
Market Segmentation
- By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Central Vertigo
- Peripheral Vertigo
- By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
- Medication
- Anticholinergics
- Antihistamines
- Benzodiazepines
- Others
- Surgery/Therapy
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Topical
- Parenteral
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Abbott Laboratories
- Siemens Healthineers
- Johnson & Johnson
- Oticon
- Cochlear Limited
- Auris Medical Holding AG
- Otonomy, Inc.
- Sensorion SA
- Sound Pharmaceuticals, Inc.
- GSK (GlaxoSmithKline)
- Merck & Co.
- Pfizer Inc.
- Novartis AG
- Bayer AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Vertigo Treatments Market, By Type
- Global Vertigo Treatments Market, By Treatment
- Global Vertigo Treatments Market, By Route of Administration
- Global Vertigo Treatments Market, By End User
- Global Vertigo Treatments Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Vertigo Treatments Market, By Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Central Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Peripheral Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Vertigo Treatments Market, By Treatment, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Anticholinergics
- Antihistamines
- Benzodiazepines
- Others
- Surgery/Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Vertigo Treatments Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Vertigo Treatments Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Vertigo Treatments Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oticon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cochlear Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Auris Medical Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Otonomy, Inc.
- Sensorion SA
- Sound Pharmaceuticals, Inc.
- GSK (GlaxoSmithKline)
- Merck & Co.
- Pfizer Inc.
- Novartis AG
- Bayer AG
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
